Structural and Thermodynamic Characteristics of Amyloidogenic Intermediates of β-2-Microglobulin

Song-Ho Chong1, Jooyeon Hong1, Sulgi Lim1

  • 1Department of Chemistry, Sookmyung Women's University, Cheongpa-ro-47-gil 100, Yongsan-ku, Seoul, 140-742, Korea.

Scientific Reports
|September 9, 2015
PubMed

Insights

Beta-2-microglobulin (β2m) forms amyloid fibrils in dialysis patients. Molecular dynamics simulations reveal key structural and thermodynamic changes in aggregation-prone states, explaining mutation effects on amyloid formation.

Area of Science:

  • Biochemistry
  • Structural Biology
  • Computational Biology

Background:

  • Beta-2-microglobulin (β2m) amyloidosis is a complication in patients undergoing long-term dialysis.
  • The molecular determinants of β2m's amyloidogenic potential remain incompletely understood.
  • Previous studies focused on structural and mutation analyses, but lacked detailed mechanistic insights.

Purpose of the Study:

  • To elucidate the molecular factors governing β2m's amyloidogenic potential.
  • To investigate the structural and thermodynamic differences between native and aggregation-prone states of β2m.
  • To correlate simulation findings with experimental observations of mutant β2m

Main Methods:

  • Molecular dynamics simulations of wild-type and mutant β2m (D76N, D59P, W60C).
  • Analysis of native (N) and aggregation-prone intermediate (IT) states, distinguished by Pro32 conformation.
  • Solvation thermodynamic analyses to assess protein-solvent interactions.

Main Results:

  • Identified three key characteristics of the IT state contributing to amyloidogenesis: disrupted D-strand, increased solvent-exposed hydrophobic interface, and higher solvation free energy.
  • Observed that mutations D76N and D59P enhance these amyloidogenic factors, while W60C decreases them.
  • Demonstrated a strong correlation between simulation results and experimentally determined amyloidogenic propensity of the mutants.

Conclusions:

  • The study identifies specific structural and thermodynamic signatures of the β2m aggregation intermediate.
  • These findings provide molecular insights into the driving forces behind β2m amyloid fibril formation.
  • Understanding these mechanisms can inform strategies to prevent or treat β2m amyloidosis.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
13.0K
Amyloid Fibrils03:03

Amyloid Fibrils

7.0K
Protein Folding01:22

Protein Folding

Overview
130.8K
Protein Folding01:25

Protein Folding

Proteins are chains of amino acids linked together by peptide bonds. Upon synthesis, a protein folds into a three-dimensional conformation, critical to its biological function. Interactions between its constituent amino acids guide protein folding, and hence the protein structure is primarily dependent on its amino acid sequence.
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
12.6K
Protein Organization01:13

Protein Organization

Overview
161.9K
Protein Organization01:24

Protein Organization

Proteins are polymers of amino acid residues. They are versatile and responsible for different cellular functions, including DNA replication, molecular transport, catalysis, and structural support. Proteins have a hierarchical structure comprising at least three levels of organization: primary, secondary, and tertiary structure. Some large proteins have a quaternary structure where individual protein subunits are linked together.
The primary structure of a protein is its amino acid sequence....
10.0K